TaeWoong Medical USA, a leader in minimally invasive gastrointestinal (GI) solutions, is proud to announce an exclusive U.S. distribution agreement with FINEMEDIX, the South Korean innovator behind the new ClearTip FNA/FNB/Franseen EUS Needle Series.

ClearTip offers a versatile, high-performance needle family customized for ultrasound‑guided (EUS) tissue sampling. Each variant features ergonomic design and specialized tip configurations, including back‑cut bevel, bidirectional blade and Franseen tip, to enhance precision, safety and visibility during procedures. Adjustable locking systems allow for simple one‑handed control and depth customization, while spiral‑etch visualization improves needle tracking under ultrasound imaging.

Key Highlights of the Partnership:

• Exclusive U.S. Rights — This agreement gives TaeWoong Medical USA the sole U.S. distribution rights for ClearTip across all relevant channels.
• Enhanced Endoscopic Offerings — ClearTip adds a diagnostic complement to TaeWoong’s already robust portfolio of stents, RFA tools and GI accessories, creating a comprehensive solution for EUS-guided workflows.
• Commitment to Innovation — TaeWoong will lead the U.S. launch strategy, including clinical training, targeted marketing initiatives, and provider outreach to highlight ClearTip’s advanced design and capabilities.

“ClearTip aligns perfectly with our mission to deliver meaningful tools that elevate patient care and procedural efficiency,” said Minsoo Seo, CEO, TaeWoong Medical USA. “Its thoughtful design and versatility will empower physicians during EUS-guided sampling and enrich our endoscopic product offering.”